Sign Up to like & get
recommendations!
0
Published in 2019 at "AntiCancer Research"
DOI: 10.21873/anticanres.13910
Abstract: Background/Aim: The objective of this phase I study was to determine the maximum-tolerated dose (MTD) and recommended dose (RD) of combination therapy with weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) and cyclophosphamide (CPA) in metastatic breast cancer…
read more here.
Keywords:
nanoparticle albumin;
therapy weekly;
weekly nanoparticle;
phase study ... See more keywords